Triple-negative breast cancer (TNBC) is a molecular subtype of BC where the three receptors estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER-2) are unexpressed [4]. Here, ERBB2 is linked to triple-negative breast carcinoma.